- Business Wire•14 hours ago
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that it will webcast its upcoming R&D Day, including a live video stream, on the Investors section of the company’s website, www.alnylam.com, on the morning of December 16, 2016.
- Motley Fool•2 days ago
Alnylam Pharmaceuticals rebounded in a big way last month.
- Investopedia•3 days ago
Alnylam's hemophilia drug fitusiran was shown safe and effective in mid-stage clinical trials.
ALNY : Summary for Alnylam Pharmaceuticals, Inc. - Yahoo Finance
Alnylam Pharmaceuticals, Inc. (ALNY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||40.08 x 200|
|Ask||44.06 x 200|
|Day's Range||39.28 - 40.99|
|52 Week Range||31.38 - 98.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-8.98|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|